Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 4150 | 43.245 |
09:34 ET | 2250 | 42.91 |
09:36 ET | 606 | 42.915 |
09:38 ET | 100 | 42.915 |
09:39 ET | 175 | 42.86 |
09:41 ET | 2102 | 42.74 |
09:43 ET | 2878 | 42.85 |
09:45 ET | 1200 | 42.695 |
09:48 ET | 1617 | 42.79 |
09:50 ET | 700 | 42.795 |
09:52 ET | 400 | 42.905 |
09:54 ET | 800 | 42.82 |
09:56 ET | 700 | 42.74 |
09:57 ET | 930 | 42.76 |
09:59 ET | 100 | 42.78 |
10:01 ET | 1105 | 42.75 |
10:03 ET | 200 | 42.745 |
10:06 ET | 979 | 42.685 |
10:08 ET | 2200 | 42.76 |
10:10 ET | 9003 | 42.65 |
10:12 ET | 9321 | 42.78 |
10:14 ET | 1200 | 42.86 |
10:15 ET | 700 | 42.85 |
10:17 ET | 1000 | 42.79 |
10:19 ET | 1700 | 42.95 |
10:21 ET | 1501 | 42.93 |
10:24 ET | 200 | 43.025 |
10:26 ET | 3435 | 43.05 |
10:28 ET | 900 | 43.13 |
10:30 ET | 1165 | 43.13 |
10:32 ET | 600 | 43.13 |
10:33 ET | 838 | 43.17 |
10:35 ET | 1600 | 43.07 |
10:37 ET | 1040 | 43.07 |
10:39 ET | 400 | 43.03 |
10:42 ET | 1281 | 43.03 |
10:44 ET | 300 | 42.925 |
10:46 ET | 1484 | 43.06 |
10:48 ET | 956 | 43 |
10:50 ET | 1050 | 42.97 |
10:51 ET | 732 | 42.9578 |
10:53 ET | 4375 | 43 |
10:55 ET | 1300 | 42.97 |
10:57 ET | 500 | 43 |
11:00 ET | 2765 | 43.04 |
11:02 ET | 850 | 42.945 |
11:04 ET | 600 | 42.945 |
11:06 ET | 1708 | 42.95 |
11:08 ET | 6026 | 42.98 |
11:09 ET | 1706 | 43.015 |
11:11 ET | 600 | 43.02 |
11:13 ET | 960 | 42.97 |
11:15 ET | 2273 | 43.01 |
11:18 ET | 1010 | 42.99 |
11:20 ET | 1249 | 42.99 |
11:22 ET | 1200 | 43 |
11:24 ET | 1500 | 43.01 |
11:26 ET | 1135 | 43.01 |
11:27 ET | 2000 | 43.015 |
11:29 ET | 829 | 42.99 |
11:31 ET | 976 | 42.98 |
11:33 ET | 1200 | 42.98 |
11:36 ET | 701 | 43.01 |
11:38 ET | 1700 | 43.04 |
11:40 ET | 600 | 43.06 |
11:42 ET | 857 | 43.095 |
11:44 ET | 1200 | 43.07 |
11:45 ET | 1300 | 43.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 6.3B | -16.8x | --- |
Halozyme Therapeutics Inc | 5.0B | 18.8x | --- |
Apellis Pharmaceuticals Inc | 5.6B | -10.6x | --- |
Intra-Cellular Therapies Inc | 7.7B | -49.4x | --- |
Blueprint Medicines Corp | 6.0B | -12.7x | --- |
ACADIA Pharmaceuticals Inc | 2.8B | -45.9x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.3B |
---|---|
Revenue (TTM) | $787.6M |
Shares Outstanding | 145.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.37 |
EPS | $-2.56 |
Book Value | $2.68 |
P/E Ratio | -16.8x |
Price/Sales (TTM) | 8.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.